Dr. Phillip Scherer's Study Group (IMAGE) UT Southwestern Medical Center Caption A study led by Dr. Phillip Scherer (l-r), Jonathan Xia, and Dr. William Holland determined that reducing concentrations of the fatty molecule ceramide improves insulin sensitivity, offering potential as a new therapy for diabetes. Credit UT Southwestern Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.